The DOI matches its Crossref record; 140 of the 140 references it cites were found in a registry or an index.
Development and evolution of therapies targeted to the estrogen receptor for the treatment and prevention of breast cancer
Open accessOverview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Fisher, B., Costantino, J. P., Wickerham, D. L., Redmond, C. K., Kavanah, M., Cronin, W. M., Vogel, V., Robidoux, A., Dimitrov, N., Atkins, J., et al. (1998) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/90.18.1371 · Cited by 5,485
Tamoxifen for early breast cancer: an overview of the randomised trials
(1998) · The Lancet · doi:10.1016/s0140-6736(97)11423-4 · Cited by 4,085
Systemic treatment of early breast cancer by hormonal, cytotoxic, or immune therapy
Early Breast Cancer Trialist's Collaborative Group (1992) · The Lancet · doi:10.1016/0140-6736(92)90997-h · Cited by 2,182
Cummings, S. R., Eckert, S., Krueger, K. A., Grady, D., Powles, T. J., Cauley, J. A., Norton, L., Nickelsen, T., Bjarnason, N. H., Morrow, M., et al. (1999) · JAMA · doi:10.1001/jama.281.23.2189 · Cited by 1,872
Self-citationGoss, P. E., Ingle, J. N., Martino, S., Robert, N. J., Muss, H. B., Piccart, M. J., Castiglione, M., Tu, D., Shepherd, L. E., Pritchard, K. I., et al. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa032312 · Cited by 1,795
Coombes, R. C., Hall, E., Gibson, L. J., Paridaens, R., Jassem, J., Delozier, T., Jones, S. E., Alvarez, I., Bertelli, G., Ortmann, O., et al. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa040331 · Cited by 1,759
A Comparison of Letrozole and Tamoxifen in Postmenopausal Women with Early Breast Cancer
(2005) · New England Journal of Medicine · doi:10.1056/nejmoa052258 · Cited by 1,577
Sexual Differentiation of the Central Nervous System
MacLusky, N. J., & Naftolin, F. (1981) · Science · doi:10.1126/science.6163211 · Cited by 1,469
Fisher, B., Costantino, J. P., Wickerham, D. L., Cecchini, R. S., Cronin, W. M., Robidoux, A., Bevers, T. B., Kavanah, M. T., Atkins, J. N., Margolese, R. G., et al. (2005) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/dji372 · Cited by 1,339
Fisher, B., Costantino, J. P., Redmond, C. K., Fisher, E. R., Wickerham, D. L., Cronin, W. M., & Contributors, O. N. (1994) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/86.7.527 · Cited by 1,268
Effects of Tamoxifen on Bone Mineral Density in Postmenopausal Women with Breast Cancer
Love, R. R., Mazess, R. B., Barden, H. S., Epstein, S., Newcomb, P. A., Jordan, V. C., Carbone, P. P., & DeMets, D. L. (1992) · New England Journal of Medicine · doi:10.1056/nejm199203263261302 · Cited by 1,129
Self-citation(1991) · PubMed · Cited by 1,101
Effects of Raloxifene on Cardiovascular Events and Breast Cancer in Postmenopausal Women
Barrett-Connor, E., Mosca, L., Collins, P., Geiger, M. J., Grady, D., Kornitzer, M., McNabb, M. A., & Wenger, N. K. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa062462 · Cited by 1,048
Winer, E. P., Hudis, C., Burstein, H. J., Wolff, A. C., Pritchard, K. I., Ingle, J. N., Chlebowski, R. T., Gelber, R., Edge, S. B., Gralow, J., et al. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.09.121 · Cited by 1,031
Mouridsen, H., Gershanovich, M., Sun, Y., Pérez-Carrión, R., Boni, C., Monnier, A., Apffelstaedt, J., Smith, R., Sleeboom, H. P., Jänicke, F., et al. (2001) · Journal of Clinical Oncology · doi:10.1200/jco.2001.19.10.2596 · Cited by 1,015
Nabholtz, J. M., Buzdar, A., Pollak, M., Harwin, W., Burton, G., Mangalik, A., Steinberg, M., Webster, A., & von Euler, M. (2000) · Journal of Clinical Oncology · doi:10.1200/jco.2000.18.22.3758 · Cited by 992
Early Breast Cancer Trialists’ Collaborative Group, & Peto, R. (1993) · Recent Results in Cancer Research · doi:10.1007/978-3-642-84745-5_21 · Cited by 958
Effects of Adjuvant Tamoxifen and of Cytotoxic Therapy on Mortality in Early Breast Cancer
Early Breast Cancer Trialists' Collaborative Group (1988) · New England Journal of Medicine · doi:10.1056/nejm198812293192601 · Cited by 933
Coregulator Function: A Key to Understanding Tissue Specificity of Selective Receptor Modulators
Smith, C. L., & O’Malley, B. W. (2004) · Endocrine Reviews · doi:10.1210/er.2003-0023 · Cited by 931
ADJUVANT TAMOXIFEN IN EARLY BREAST CANCER: OCCURRENCE OF NEW PRIMARY CANCERS
Fornander, T., Cedermark, B., Mattsson, A., Skoog, L., Theve, T., Askergren, J., Rutqvist, L., Glas, U., Silfverswärd, C., Somell, A., et al. (1989) · The Lancet · doi:10.1016/s0140-6736(89)91141-0 · Cited by 920
Howell, A. (1998) · PubMed · Cited by 901
The ATAC (Arimidex, T. A. O. I. C. T. G. (2003) · Cancer · doi:10.1002/cncr.11745 · Cited by 861
Bonneterre, J., Thürlimann, B., Robertson, J. F. R., Krzakowski, M., Mauriac, L., Koralewski, P., Vergote, I., Webster, A., Steinberg, M., & von Euler, M. (2000) · Journal of Clinical Oncology · doi:10.1200/jco.2000.18.22.3748 · Cited by 842
Tamoxifen: a most unlikely pioneering medicine
Jordan, V. C. (2003) · Nature Reviews Drug Discovery · doi:10.1038/nrd1031 · Cited by 824
Self-citationCummings, S. R. (1999) · Medical Entomology and Zoology · Cited by 797
Mammary Cancer Induced by a Single Feeding of Polynuclear Hydrocarbons, and its Suppression
HUGGINS, C., GRAND, L. C., & BRILLANTES, F. P. (1961) · Nature · doi:10.1038/189204a0 · Cited by 786
Simpson, E. R., Clyne, C., Rubin, G., Boon, W. C., Robertson, K., Britt, K., Speed, C., & Jones, M. (2002) · Annual Review of Physiology · doi:10.1146/annurev.physiol.64.081601.142703 · Cited by 773
Advances in Comparative and Environmental Physiology: Volume 7
Houlihan, D. F., Livingstone, D. R., & Lee, R. F. (1991) · Advances in Comparative and Environmental Physiology · doi:10.1007/978-3-642-75897-3 · Cited by 738
A New Anti-oestrogenic Agent in Late Breast Cancer: An Early Clinical Appraisal of ICI46474
Cole, M. P., Jones, C. T. A., & Todd, I. D. H. (1971) · British Journal of Cancer · doi:10.1038/bjc.1971.33 · Cited by 701
Effects of Raloxifene on Serum Lipids and Coagulation Factors in Healthy Postmenopausal Women
Walsh, B. W. (1998) · JAMA · doi:10.1001/jama.279.18.1445 · Cited by 692
Cauley, J. A., Norton, L., Lippman, M. E., Eckert, S., Krueger, K. A., Purdie, D. W., Farrerons, J., Karasik, A., Mellstrom, D., Ng, K. W., et al. (2001) · Breast Cancer Research and Treatment · doi:10.1023/a:1006478317173 · Cited by 678
Self-citationFisher, B., Dignam, J., Bryant, J., & Wolmark, N. (2001) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/93.9.684 · Cited by 635
Bonneterre, J., Buzdar, A., Nabholtz, J.-M. A., Robertson, J. F. R., Th�rlimann, B., von Euler, M., Sahmoud, T., Webster, A., Steinberg, M., & Arimidex Writing Committee on behalf of the Investigators Committee Members (2001) · Cancer · doi:10.1002/1097-0142(20011101)92:9<2247::aid-cncr1570>3.0.co;2-y · Cited by 574
The estrogen receptor: a model for molecular medicine.
Jensen, E. V., & Jordan, V. C. (2003) · PubMed · Cited by 573
Self-citation(1981) · The Lancet · doi:10.1016/s0140-6736(81)91281-2 · Cited by 544
A MONOHYDROXYLATED METABOLITE OF TAMOXIFEN WITH POTENT ANTIOESTROGENIC ACTIVITY
JORDAN, V. C., COLLINS, M. M., ROWSBY, L., & PRESTWICH, G. (1977) · Journal of Endocrinology · doi:10.1677/joe.0.0750305 · Cited by 506
Self-citationvan Landeghem, A. A. J., Poortman, J., Nabuurs, M., & Thijssen, J. H. H. (1985) · PubMed · Cited by 448
A NEW DERIVATIVE OF TRIPHENYLETHYLENE: EFFECT ON IMPLANTATION AND MODE OF ACTION IN RATS
HARPER, M. J. K., & WALPOLE, A. L. (1967) · Reproduction · doi:10.1530/jrf.0.0130101 · Cited by 445
HEMSELL, D. L., GRODIN, J. M., BRENNER, P. F., SIITERI, P. K., & MACDONALD, P. C. (1974) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-38-3-476 · Cited by 444
Wijayaratne, A. L., & McDonnell, D. P. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m101097200 · Cited by 427
Estrogen receptors and breast cancer response to adrenalectomy.
Jensen, E. V., Block, G. E., Smith, S. B., Kyser, K., & DeSombre, E. R. (1971) · PubMed · Cited by 423
Contrasting actions of tamoxifen on endometrial and breast tumor growth in the athymic mouse.
Gottardis, M. M., Robinson, S. P., SATYASWAROOP, P. G., & Jordan, V. C. (1988) · PubMed · Cited by 422
Self-citationDevelopment of antiestrogens and their use in breast cancer: eighth Cain memorial award lecture.
Lerner, L. J., & Jordan, V. C. (1990) · PubMed · Cited by 417
Self-citationBiochemical pharmacology of antiestrogen action.
Jordan, V. C. (1984) · Pharmacological Reviews · doi:10.1016/s0031-6997(25)06650-5 · Cited by 417
Self-citationJordan, V. C. (2003) · Journal of Medicinal Chemistry · doi:10.1021/jm020449y · Cited by 414
Self-citationCavalieri, E., Chakravarti, D., Guttenplan, J., Hart, E., Ingle, J., Jankowiak, R., Muti, P., Rogan, E., Russo, J., Santen, R., et al. (2006) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2006.03.001 · Cited by 409
Jordan, V. C. (2003) · Journal of Medicinal Chemistry · doi:10.1021/jm020450x · Cited by 396
Self-citationAromatization of Androgens by Muscle and Adipose Tissue in Vivo*
LONGCOPE, C., PRATT, J. H., STEPHEN, H. S., & FINEBERG, S. E. (1978) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-46-1-146 · Cited by 392
Gottardis, M. M., & Jordan, V. C. (1987) · PubMed · Cited by 378
Self-citationEARLYBREASTCANCERTRIALISTSCOL (1992) · The Lancet · doi:10.1016/0140-6736(92)90139-t · Cited by 375
Effects of Tamoxifen on Cardiovascular Risk Factors in Postmenopausal Women
Love, R. R., Wiebe, D. A., Newcomb, P. A., Cameron, L., Leventhal, H., Jordan, V. C., Feyzi, J., & DeMets, D. L. (1991) · Annals of Internal Medicine · doi:10.7326/0003-4819-115-11-860 · Cited by 374
Self-citationEffect of tamoxifen (ICI 46,474) on initiation and growth of DMBA-induced rat mammary carcinomata
Jordan, V. C. (1976) · European Journal of Cancer (1965) · doi:10.1016/0014-2964(76)90030-x · Cited by 371
Self-citationBRODIE, A. M. H., SCHWARZEL, W. C., SHAIKH, A. A., & BRODIE, H. J. (1977) · Endocrinology · doi:10.1210/endo-100-6-1684 · Cited by 365
Self-citationJefcoate, C. R. (1978) · Methods in Enzymology · doi:10.1016/s0076-6879(78)52029-6 · Cited by 358
High-grade endometrial carcinoma in tamoxifen-treated breast cancer patients.
Magriples, U., Naftolin, F., Schwartz, P. E., & Carcangiu, M. L. (1993) · Journal of Clinical Oncology · doi:10.1200/jco.1993.11.3.485 · Cited by 350
Structural Insights into the Mode of Action of a Pure Antiestrogen
Pike, A. C. W., Brzozowski, A. M., Walton, J., Hubbard, R. E., Thorsell, A.-G., Li, Y.-L., Gustafsson, J.-Å., & Carlquist, M. (2001) · Structure · doi:10.1016/s0969-2126(01)00568-8 · Cited by 347
Vogel, V. G., Costantino, J. P., Wickerham, D. L., Cronin, W. M., Cecchini, R. S., Atkins, J. N., Bevers, T. B., Fehrenbacher, L., Pajon, E. R., Wade, J. L., et al. (2006) · Obstetrical & Gynecological Survey · doi:10.1097/01.ogx.0000238648.23538.42 · Cited by 329
Self-citationEffects of anti-estrogens on bone in castrated and intact female rats
Jordan, V. C., Phelps, E., & Lindgren, J. U. (1987) · Breast Cancer Research and Treatment · doi:10.1007/bf01806132 · Cited by 324
Self-citationLønning, P. E., Bajetta, E., Murray, R., Tubiana-Hulin, M., Eisenberg, P. D., Mickiewicz, E., Celio, L., Pitt, P., Mita, M., Aaronson, N. K., et al. (2000) · Journal of Clinical Oncology · doi:10.1200/jco.2000.18.11.2234 · Cited by 316
Selective estrogen receptor modulation
Jordan, V. C. (2004) · Cancer Cell · doi:10.1016/s1535-6108(04)00059-5 · Cited by 315
Self-citationGoss, P. E., Ingle, J. N., Martino, S., Robert, N. J., Muss, H. B., Piccart, M. J., Castiglione, M., Tu, D., Shepherd, L. E., Pritchard, K. I., et al. (2004) · Obstetrical & Gynecological Survey · doi:10.1097/01.ogx.0000115858.45890.53 · Cited by 315
Geisler, J., King, N. C., Anker, G. B., Ornati, G., di Salle, E., Lønning, P. E., & Dowsett, M. (1998) · PubMed · Cited by 314
SCHWARZEL, W. C., KRUGGEL, W. G., & BRODIE, H. J. (1973) · Endocrinology · doi:10.1210/endo-92-3-866 · Cited by 303
Love, R. R., Newcomb, P. A., Wiebe, D. A., Surawicz, T. S., Jordan, V. C., Carbone, P. P., & DeMets, D. L. (1990) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/82.16.1327 · Cited by 292
Self-citationTamoxifen (ICI46,474) as a targeted therapy to treat and prevent breast cancer
Jordan, V. C. (2006) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0706399 · Cited by 292
Self-citationModels of estrogen receptor regulation by estrogens and antiestrogens in breast cancer cell lines.
Pink, J. J., & Jordan, V. C. (1996) · PubMed · Cited by 276
Self-citationCASH, R., BROUGH, A. J., COHEN, M. N. P., & SATOH, P. S. (1967) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-27-9-1239 · Cited by 260
Dawson, J. H., Andersson, L. A., & Sono, M. (1982) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)34823-3 · Cited by 256
(2006) · Journal of Clinical Oncology · doi:10.1200/jco.2005.03.0783 · Cited by 244
Lewis, J. S., Meeke, K., Osipo, C., Ross, E. A., Kidawi, N., Li, T., Bell, E., Chandel, N. S., & Jordan, V. C. (2005) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/dji400 · Cited by 244
Self-citationTamoxifen prevents the skeletal effects of ovarian hormone deficiency in rats
Turner, R. T., Wakley, G. K., Hannon, K. S., & Bell, N. H. (1987) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.5650020513 · Cited by 242
Antagonism of estrogen action with a new benzothiophene derived antiestrogen
Black, L. J., Jones, C. D., & Falcone, J. F. (1983) · Life Sciences · doi:10.1016/0024-3205(83)90935-9 · Cited by 239
URINARY INFECTION IN THE TWO SEXES
Smallpeice, V. (1966) · The Lancet · doi:10.1016/s0140-6736(66)92942-4 · Cited by 237
Estrogen Receptors as Therapeutic Targets in Breast Cancer
Ariazi, E. A., & Jordan, V. C. (2008) · Methods and Principles in Medicinal Chemistry · doi:10.1002/9783527623297.ch5 · Cited by 230
Self-citationParidaens, R., Dirix, L., Lohrisch, C., Beex, L., Nooij, M., Cameron, D., Biganzoli, L., Cufer, T., Duchateau, L., Hamilton, A., et al. (2003) · Annals of Oncology · doi:10.1093/annonc/mdg362 · Cited by 230
Lønning, P. E., Taylor, P. D., Anker, G., Iddon, J., Wie, L., Jørgensen, L.-M., Mella, O., & Howell, A. (2001) · Breast Cancer Research and Treatment · doi:10.1023/a:1010619225209 · Cited by 226
TURNER, R. T., WAKLEY, G. K., HANNON, K. S., & BELL, N. H. (1988) · Endocrinology · doi:10.1210/endo-122-3-1146 · Cited by 224
Brodie, A. M. H., Garrett, W. M., Hendrickson, J. R., Tsai-Morris, C.-H., Marcotte, P. A., & Robinson, C. H. (1981) · Steroids · doi:10.1016/0039-128x(81)90087-8 · Cited by 215
Self-citationJordan, V. C., & Allen (née Naylor), K. E. (1980) · European Journal of Cancer (1965) · doi:10.1016/0014-2964(80)90156-5 · Cited by 214
Self-citationSanten, R. J., Worgul, T. J., Samojlik, E., Interrante, A., Boucher, A. E., Lipton, A., Harvey, H. A., White, D. S., Smart, E., Cox, C., et al. (1981) · New England Journal of Medicine · doi:10.1056/nejm198109033051003 · Cited by 203
Effects of Tamoxifen on Spinal Bone Density in Women With Breast Cancer
Turken, S., Siris, E., Seldin, D., Flaster, E., Hyman, G., & Lindsay, R. (1989) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/81.14.1086 · Cited by 194
Tamoxifen (ICI 46,474) and the human carcinoma 8S oestrogen receptor
Jordan, V. C., & Koerner, S. (1975) · European Journal of Cancer (1965) · doi:10.1016/0014-2964(75)90119-x · Cited by 186
Self-citationWasan, K. M., Goss, P. E., Pritchard, P. H., Shepherd, L., Palmer, M. J., Liu, S., Tu, D., Ingle, J. N., Heath, M., DeAngelis, D., et al. (2005) · Annals of Oncology · doi:10.1093/annonc/mdi158 · Cited by 179
Selective estrogen receptor modulation: a personal perspective.
Jordan, V. C. (2001) · PubMed · Cited by 174
Self-citationUse of aromatase inhibitors in breast carcinoma.
Santen, R. J., & Harvey, H. A. (1999) · Endocrine-related cancer · doi:10.1677/erc.0.0060075 · Cited by 165
17‐Beta‐Estradiol induces transformation and tumorigenesis in human breast epithelial cells
Russo, J., Fernandez, S. V., Russo, P. A., Fernbaugh, R., Sheriff, F. S., Lareef, H. M., Garber, J., & Russo, I. H. (2006) · The FASEB Journal · doi:10.1096/fj.05-5399com · Cited by 161
Apoptotic Action of 17 -Estradiol in Raloxifene-Resistant MCF-7 Cells In Vitro and In Vivo
Liu, H., Lee, E.-S., Gajdos, C., Pearce, S. T., Chen, B., Osipo, C., Loweth, J., McKian, K., Reyes, A. D. L., Wing, L., et al. (2003) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djg080 · Cited by 161
Self-citationEvans, T. R. J., di Salle, E., Ornati, G., Lassus, M., Benedetti, M. S., Pianezzola, E., & Coombes, R. C. (1992) · PubMed · Cited by 149
Tissue-specific promoters regulate aromatase cytochrome P450 expression
Simpson, E. R., Mahendroo, M., Means, G., Kilgore, M. W., Corbin, C. J., & Mendelson, C. R. (1993) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/0960-0760(93)90235-o · Cited by 146
Jelovac, D., Sabnis, G. J., Long, B. J., Macedo, L. F., Goloubeva, O. G., & Brodie, A. M. H. (2005) · Cancer Research · doi:10.1158/0008-5472.can-04-4502 · Cited by 141
Self-citationLong, B. J., Jelovac, D., Handratta, V. D., Thiantanawat, A., Macpherson, N. A., Ragaz, J., Goloubeva, O. G., & Brodie, A. M. H. (2004) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djh076 · Cited by 141
Self-citationSubstrate-induced inactivation of aromatase by allenic and acetylenic steroids
Metcalf, B. W., Wright, C. L., Burkhart, J. P., & Johnston, J. O. (1981) · Journal of the American Chemical Society · doi:10.1021/ja00401a054 · Cited by 141
Clomiphene protects against osteoporosis in the mature ovariectomized rat
Beall, P. T., Misra, L. K., Young, R. L., Spjut, H. J., Evans, H. J., & LeBlanc, A. (1984) · Calcified Tissue International · doi:10.1007/bf02405304 · Cited by 140
TAMOXIFEN AS AN ANTI-TUMOUR AGENT: EFFECT ON OESTROGEN BINDING
Jordan, V. C., & DOWSE, L. J. (1976) · Journal of Endocrinology · doi:10.1677/joe.0.0680297 · Cited by 133
Self-citationOsipo, C., Gajdos, C., Liu, H., Chen, B., & Jordan, V. C. (2003) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djg079 · Cited by 131
Self-citationGottardis, M. M., Ricchio, M. E., SATYASWAROOP, P. G., et al. (1990) · PubMed · Cited by 128
Estrogen-induced apoptosis in a breast cancer model resistant to long-term estrogen withdrawal
Lewis, J. S., Osipo, C., Meeke, K., & Jordan, V. C. (2005) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2004.12.032 · Cited by 128
Self-citationJelovac, D., Macedo, L. F., Goloubeva, O. G., Handratta, V. D., & Brodie, A. M. H. (2005) · Cancer Research · doi:10.1158/0008-5472.can-04-2782 · Cited by 123
Self-citationHong, Y., Yu, B., Sherman, M. A., Yuan, Y., Zhou, D., & Chen, S. (2006) · Molecular Endocrinology · doi:10.1210/me.2006-0281 · Cited by 123
The Final Catalytic Step of Cytochrome P450 Aromatase: A Density Functional Theory Study
Hackett, J. C., Brueggemeier, R. W., & Hadad, C. M. (2005) · Journal of the American Chemical Society · doi:10.1021/ja044716w · Cited by 122
Adaptation of estrogen-dependent MCF-7 cells to low estrogen (phenol red-free) culture
Welshons, W. V., & Jordan, V. C. (1987) · European Journal of Cancer and Clinical Oncology · doi:10.1016/0277-5379(87)90062-9 · Cited by 122
Self-citationRavdin, P., Fritz, N. F., Tormey, D. C., & Jordan, V. C. (1988) · PubMed · Cited by 122
Self-citationSuicide enzyme inhibitors as potential drugs
Sjoerdsma, A. (1981) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.1981.121 · Cited by 117
Paridaens, R., Therasse, P., Dirix, L. Y., Beex, L. V. A. M., Piccart, M. J., Cameron, D., Cufer, T., Roozendaal, K. J., Nooij, M. A., & Mattiacci, M. R. (2004) · Journal of Clinical Oncology · doi:10.1200/jco.2004.22.90140.515 · Cited by 114
Zhao, Y., Agarwal, V. R., Mendelson, C. R., & Simpson, E. R. (1997) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/s0960-0760(97)80013-1 · Cited by 112
Studies on the mechanism of estrogen biosynthesis in the rat ovary–I
Brodie, A. M. H., Schwarzel, W. C., & Brodie, H. J. (1976) · Journal of Steroid Biochemistry · doi:10.1016/0022-4731(76)90180-1 · Cited by 112
Self-citationSteroid Metabolism and the Activation of Social Behavior
Balthazart, J. (1989) · Advances in comparative and environmental physiology · doi:10.1007/978-3-642-73827-2_3 · Cited by 99
Tormey, D. C., & Jordan, V. C. (1984) · Breast Cancer Research and Treatment · doi:10.1007/bf01806042 · Cited by 99
Self-citationBrodie, A. M. H., & Longcope, C. (1980) · Endocrinology · doi:10.1210/endo-106-1-19 · Cited by 99
Self-citationMedical adrenalectomy using aminoglutethimide and dexamethasone in advanced breast cancer
Lipton, A., & Santen, R. J. (1974) · Cancer · doi:10.1002/1097-0142(197402)33:2<503::aid-cncr2820330227>3.0.co;2-l · Cited by 98
SAMOJLIK, E., Santen, R. J., & Wells, S. A. (1977) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-45-3-480 · Cited by 95
Brodie, A., Lü, Q., & Long, B. J. (1999) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/s0960-0760(99)00051-5 · Cited by 90
Self-citationFavia, A. D., Cavalli, A., Masetti, M., Carotti, A., & Recanatini, M. (2006) · Proteins Structure Function and Bioinformatics · doi:10.1002/prot.20829 · Cited by 86
Pink, J., Bilimoria, M. M., Assikis, J., & Jordan, V. C. (1996) · British Journal of Cancer · doi:10.1038/bjc.1996.521 · Cited by 85
Self-citationDemers, L. M., Lipton, A., Harvey, H. A., Kambic, K. B., Grossberg, H., Brady, C., & Santen, R. J. (1993) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/0960-0760(93)90283-3 · Cited by 83
Inkster, S. E., & Brodie, A. M. H. (1991) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-73-4-717 · Cited by 79
Self-citationEvaluation of the mechanism of aromatase cytochrome P450. A site-directed mutagenesis study
Kao, Y., Korzekwa, K. R., Laughton, C. A., & Chen, S. (2001) · European Journal of Biochemistry · doi:10.1046/j.1432-1033.2001.01886.x · Cited by 79
Jordan, V. C. (1988) · Cancer Investigation · doi:10.3109/07357908809082124 · Cited by 75
Self-citationSafi, R., Kovacic, A., Gaillard, S. L., Murata, Y., Simpson, E. R., McDonnell, D. P., & Clyne, C. D. (2005) · Cancer Research · doi:10.1158/0008-5472.can-05-2792 · Cited by 70
Brodie, A. M. H., Marsh, D. A., & Brodie, H. J. (1979) · Journal of Steroid Biochemistry · doi:10.1016/0022-4731(79)90330-3 · Cited by 70
Self-citationConsensus conference. Adjuvant chemotherapy for breast cancer
(1985) · JAMA · doi:10.1001/jama.254.24.3461 · Cited by 58
Breast cancer prevention—clinical trials strategies involving aromatase inhibitors
Goss, P. E. (2003) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/s0960-0760(03)00378-9 · Cited by 54
Hahn, E. F., & Fishman, J. (1984) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)43462-4 · Cited by 52
Tissue-specific promoters regulate aromatase cytochrome P450 expression
Simpson, E. R., Mahendroo, M., Means, G., Kilgore, M. W., Corbin, C. J., & Mendelson, C. R. (1993) · Clinical Chemistry · doi:10.1093/clinchem/39.2.317 · Cited by 47
The minimal effective exemestane dose for endocrine activity in advanced breast cancer
Bajetta, E., Zilembo, N., Noberasco, C., et al. (1997) · European Journal of Cancer · doi:10.1016/s0959-8049(96)00494-7 · Cited by 46
Jordan, V. C., Lewis, J. S., Osipo, C., & Cheng, D. (2005) · The Breast · doi:10.1016/j.breast.2005.08.022 · Cited by 44
Self-citationBrodie, A. M. H., Brodie, H. J., Garrett, W. M., Hendrickson, J. R., Marsh, D. A., & Tsai‐Morris, C. (1982) · Biochemical Pharmacology · doi:10.1016/0006-2952(82)90415-4 · Cited by 42
Self-citationBlankenstein, M. A., Szymczak, J., Daroszewski, J., Milenncz, A., & Thijssen, J. H. H. (1992) · Gynecological Endocrinology · doi:10.3109/09513599209081001 · Cited by 42
Zaccheo, T., Giudici, D., Ornati, G., Panzeri, A., & di Salle, E. (1991) · European Journal of Cancer and Clinical Oncology · doi:10.1016/0277-5379(91)90313-3 · Cited by 37
Conversion of a 3-desoxysteroid to 3-desoxyestrogen by human placental aromatase.
Cole, P. A., Bean, J. M., & Robinson, C. H. (1990) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.87.8.2999 · Cited by 34
Endocrine therapy of advanced disease: analysis and implications of the existing data.
Pritchard, K. I. (2003) · PubMed · Cited by 34
REVIEW OF MORTALITY RESULTS IN RANDOMISED TRIALS IN EARLY BREAST CANCER
(1984) · The Lancet · doi:10.1016/s0140-6736(84)92756-9 · Cited by 34
Estrogen Receptors as Therapeutic Targets in Breast Cancer
Ariazi, E. A., Ariazi, J. L., Cordera, F., & Jordan, V. C. (2006) · Current Topics in Medicinal Chemistry · doi:10.2174/156802606776173474 · Cited by 32
Self-citationCovey, D. F., Hood, W. F., Beusen, D. D., & Carrell, H. L. (1984) · Biochemistry · doi:10.1021/bi00318a004 · Cited by 27
Cited by
Mechanisms of Endocrine Resistance in Breast Cancer
Osborne, C. K., & Schiff, R. (2011) · Annual Review of Medicine · doi:10.1146/annurev-med-070909-182917 · Cited by 1,166
Bioactive Benzofuran derivatives: A review
Khanam, H., & Shamsuzzaman (2015) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2014.11.039 · Cited by 554
History of Aromatase: Saga of an Important Biological Mediator and Therapeutic Target
Santen, R. J., Brodie, H., Simpson, E. R., Siiteri, P. K., & Brodie, A. (2009) · Endocrine Reviews · doi:10.1210/er.2008-0016 · Cited by 442
Self-citationAndrogen Receptor Inhibits Estrogen Receptor-α Activity and Is Prognostic in Breast Cancer
Peters, A. A., Buchanan, G., Ricciardelli, C., Bianco-Miotto, T., Centenera, M. M., Harris, J. M., Jindal, S., Segara, D., Jia, L., Moore, N. L., et al. (2009) · Cancer Research · doi:10.1158/0008-5472.can-09-0452 · Cited by 405
Aromatase, aromatase inhibitors, and breast cancer
Chumsri, S., Howes, T., Bao, T., Sabnis, G., & Brodie, A. (2011) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2011.02.001 · Cited by 401
Self-citation
Metadata
- Authors
- Jordan, V. C., & Brodie, A. M. H.
- Venue
- Steroids
- Publisher
- Elsevier BV
- Published
- 2007-01
- Volume
- 72
- Issue
- 1
- Pages
- 7-25
- ISSN
- 0039-128X (ISSN-L)
- OpenAlex
- W2024606555
- Cited by
- 296
- References
- 140
- FWCI
- 11.66
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.